Medicaid Innovation Collaborative announces 5 pilot programs

The latest stories trending on MedCity News.

Editor's Pick

Top Story Medicaid Innovation Collaborative Announces 5 Pilot Programs To Improve Outcomes for Medicaid Patients The Medicaid Innovation Collaborative announced five pilot programs in Kentucky, New York and Iowa. Each program addresses the health-related social needs of Medicaid beneficiaries living with a chronic condition, like diabetes. Sponsored Content Seeking a Total Patient View? Look No Further. Presented by Medidata Solutions Gain a truly integrated experience that easily & accurately captures data from patients, caregivers and clinicians in traditional, hybrid or fully decentralized trials for a 360° patient view.  Learn More. Check Out This Pre-Conference Workshop at INVEST 2024 Did you know the U.S. Government funds startups and is a great source for small business support? Chris Sasiela, Director, Innovator SEED Innovator Support Services, from NIH will cover resources and programs available to enhance a portfolio startup's success. Including access to entrepreneurs-in-residence, subject matter experts in regulatory and reimbursement, gap analyses, entrepreneurial training and more. Secure your spot today and save. Register Now for $995 [rate ends Feb 16th]

Featured News

Health2047 CEO: As Tech Advances, the Power of Community Engagement Can't Be Forgotten In an interview last week, Larry Cohen — CEO of Health 2047, the American Medical Association's venture studio — noted that digital health programs have proven to do a good job of improving patient outcomes — but only for certain groups. As technology continues to advance, he urged healthcare leaders not to underestimate the effectiveness of engaging patients by having boots on the ground. Gilead Drug Fails Pivotal Lung Cancer Study, But Still Might Have Path Forward Gilead Sciences said even though Trodelvy missed the main goal of its Phase 3 test in non-small cell lung cancer, the drug's preliminary results show numerical improvement in patients whose disease did not respond to prior treatment with immunotherapy. The company plans to discuss with regulators a possible path forward in these patients. Breaking the Cycle: Telehealth Treatment for People in Custody is Key to Recidivism Disruption Expanding access to telehealth-based treatment programs that include medications for OUD, like buprenorphine or Sublocade, to patients as they leave custody can upend this cycle of incarceration through seamlessly following patients wherever they go next. The TREATS Act creates a legal pathway for this care to continue. Empowering Families and Enhancing Care Coordination: The Role of Discharge Coordination Software in the NICU As healthcare continues to evolve, discharge coordination software will play an increasingly important role in bridging the gap between hospital care and home care, ensuring that NICU graduates and their families receive the comprehensive support they need to thrive. Ionis Rare Disease Drug Is Headed to FDA, But Forthcoming Data Will Decide Competitive Profile In its Phase 3 test, Ionis Pharmaceuticals drug donidalorsen reduced the frequency of swelling attacks caused by the rare disease hereditary angioedema. If Ionis can commercialize this drug, competition would include products from Takeda Pharmaceutical and BioCryst Pharmaceuticals. Healthcare Docket: Will Florida's Plan to Import Drugs From Canada Open the Floodgates? No matter the outcome, it's certain that the cost of drugs will not be an issue easily resolved anytime soon even though several other states also have laws allowing for drug imports.

Resources

MedCity FemFwd: Shortcomings in Menopause Care with Dr. Bruce Dorr In this episode, we were joined by Dr. Bruce Dorr, an OB-GYN and senior medical advisor for Biote, a hormone optimization company. Just about every woman will go through menopause, yet treatment is inadequate. This comes down to the lack of medical training for menopause care, according to Dorr. He discusses why this is and what needs to change. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe